Clinical Trials · NCT03450109
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Luye Pharma Group Ltd.
- Enrollment
- 19
- Start date
- Dec 2017
- Locations
- 5 sites, United States
- Primary endpoint
- The bio-availability of goserelin in subjects receiving goserelin compared to Zoladex using Pharmacokinetic lab results